title: Harmonization efforts for deriving health-based exposure limits in the pharmaceutical industry - Advancing the current science and practice.
authors.affiliation: Genentech Inc, United States; Sakari Consultants LLC, United States. Electronic address: patricia.weideman@sakariconsultants.com.
authors.forename: Patricia A
authors.initials: PA
authors.lastname: Weideman
authors.affiliation: University of Cincinnati, Toxicology Excellence for Risk Assessment (TERA) Center, United States.
authors.forename: Alison M
authors.initials: AM
authors.lastname: Pecquet
authors.affiliation: University of Cincinnati, Toxicology Excellence for Risk Assessment (TERA) Center, United States.
authors.forename: M Andrew
authors.initials: MA
authors.lastname: Maier
mesh_terms: D000818:Animals; D004345:Drug Industry / Q000331:legislation & jurisprudence / Q000592:standards; D017408:Guidelines as Topic; D006291:Health Policy; D006801:Humans; D019055:No-Observed-Adverse-Effect Level; D016273:Occupational Exposure / Q000009:adverse effects / Q000331:legislation & jurisprudence / Q000517:prevention & control* / Q000592:standards; D016272:Occupational Health / Q000331:legislation & jurisprudence / Q000592:standards; D004364:Pharmaceutical Preparations / Q000145:classification / Q000592:standards; D011050:Policy Making; D018570:Risk Assessment; D018675:Toxicity Tests
chemical_list: D004364:Pharmaceutical Preparations